What impact has iPSC technology had on your research and/or field?
Stem Cell Reports · 2026-11 · 21 (11) · 103143
DOI: 10.1016/j.stemcr.2026.103143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2026-11. Verfasst von Masayo Takahashi und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In our field, induced pluripotent stem cell (iPSC) technology removed the final barrier between pioneering retinal stem cell research and clinical application. We had previously been the first to generate retinal pigment epithelial (RPE) cells from primate ES cells and to demonstrate their therapeutic efficacy in animal models. However, because the target diseases mainly affect elderly patients, we were deeply concerned that using allogeneic cells with systemic immunosuppression could create unacceptable clinical risks.
Zitieren
APA
Takahashi, M., Polo, J., Takahashi, K., Cosma, M. P., Pamies, D., Deng, H., Mummery, C., & Sharma, A. (2026). What impact has iPSC technology had on your research and/or field?. Stem Cell Reports, 21(11), 103143. https://doi.org/10.1016/j.stemcr.2026.103143
Vancouver
Takahashi M, Polo J, Takahashi K, Cosma MP, Pamies D, Deng H, et al. What impact has iPSC technology had on your research and/or field?. Stem Cell Reports. 2026;21(11):103143. doi:10.1016/j.stemcr.2026.103143
BibTeX
@article{Takahashi2026,
author = {Takahashi, Masayo and Polo, Jose and Takahashi, Kazutoshi and Cosma, Maria Pia and Pamies, David and Deng, Hongkui and Mummery, Christine and Sharma, Arun},
title = {What impact has iPSC technology had on your research and/or field?},
journal = {Stem Cell Reports},
year = {2026},
volume = {21},
number = {11},
pages = {103143},
doi = {10.1016/j.stemcr.2026.103143}
}
EUVIMED